» Articles » PMID: 12127669

The Nature of the Autonomic Dysfunction in Multiple System Atrophy

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2002 Jul 20
PMID 12127669
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The concept that multiple system atrophy (MSA, Shy-Drager syndrome) is a disorder of the autonomic nervous system is several decades old. While there has been renewed interest in the movement disorder associated with MSA, two recent consensus statements confirm the centrality of the autonomic disorder to the diagnosis. Here, we reexamine the autonomic pathophysiology in MSA. Whereas MSA is often thought of as "autonomic failure", new evidence indicates substantial persistence of functioning sympathetic and parasympathetic nerves even in clinically advanced disease. These findings help explain some of the previously poorly understood features of MSA. Recognition that MSA entails persistent, constitutive autonomic tone requires a significant revision of our concepts of its diagnosis and therapy. We will review recent evidence bearing on autonomic tone in MSA and discuss their therapeutic implications, particularly in terms of the possible development of a bionic baroreflex for better control of blood pressure.

Citing Articles

Clinical Correlates of Efficacy of Pyridostigmine in the Treatment of Orthostatic Hypotension.

Okamoto L, Walsh E, Diedrich A, Shibao C, Gamboa A, Black B Hypertension. 2024; 82(3):489-497.

PMID: 39727053 PMC: 11839338. DOI: 10.1161/HYPERTENSIONAHA.124.24050.


Biomarkers and Rehabilitation for Functional Neurological Disorder.

Mark V J Pers Med. 2024; 14(9).

PMID: 39338202 PMC: 11433361. DOI: 10.3390/jpm14090948.


Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial.

Mwesigwa N, Millar Vernetti P, Kirabo A, Black B, Ding T, Martinez J Clin Auton Res. 2024; 34(6):561-569.

PMID: 39294522 PMC: 11543771. DOI: 10.1007/s10286-024-01051-2.


The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy.

Kleinz T, Scholz L, Huckemann S, Rohmann R, Kuhn E, Averdunk P Ther Adv Neurol Disord. 2024; 17:17562864241267300.

PMID: 39175851 PMC: 11339749. DOI: 10.1177/17562864241267300.


Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions.

Chen B, Yang W, Luo Y, Tan E, Wang Q J Neurol. 2023; 270(11):5251-5273.

PMID: 37477834 DOI: 10.1007/s00415-023-11876-y.